Cited by 35IL-33, ST2, and ILC PathwaysT-cell and B-cell ImmunologyImmune responses and vaccinations

Innate lymphoid cells: new players in IL-17-mediated antifungal immunity

Open access
Gladiator, André, LeibundGut-Landmann, Salomé·2013·PLoS Pathogens

Abstract

ISSN:1553-7374

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1003763

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ILCs contribute to effective host defense against mucocutaneous fungal challenge.

    “ILCs contribute to effective host defense against mucocutaneous fungal challenge [92,93].”

    From Host–Candida auris interactions in the skin (2026) · cites this paper as [92]

    The section “Which Cellular Sources Provide IL-17 during Fungal Infection?” reports that depleting ILC3s makes mice highly susceptible to oropharyngeal candidiasis, supporting a role in mucosal fungal defense. It does not establish the same protective role for ILCs across cutaneous infections or in humans; the paper says the human role remains a question. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Distinct cytokine requirements exist across mucocutaneous tissues, and IL-17-producing ILCs are key effectors that maintain antifungal barrier immunity in the skin.

    “These findings highlight distinct cytokine requirements across mucocutaneous tissues and underscore IL-17-producing ILCs as key effectors that maintain antifungal barrier immunity in the skin.”

    From Host–Candida auris interactions in the skin (2026) · cites this paper as [92]

    “How Is IL-17 Production by ILCs Regulated?” describes different cytokine requirements in the oral and gut mucosa, supporting tissue-dependent regulation. But “Which Cellular Sources Provide IL-17 during Fungal Infection?” implicates ILC3s in oral candidiasis and says γδ T cells appear more important in the skin; it does not establish IL-17-producing ILCs as key effectors maintaining antifungal immunity there. (LLM, conf=0.89)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 32 · Cited by 35

Research works printed but not linked: 27

  1. [2]Puel A, Cypowyj S, Marodi L, Abel L, Picard C, et al (2012) Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 12: 616– 622. 23026768 PMC3538358
  2. [5]Rudner XL, Happel KI, Young EA, Shellito JE (2007) Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 75: 3055– 3061. 17403873 PMC1932856
  3. [6]Deepe GS Jr, Gibbons RS (2009) Interleukins 17 and 23 influence the host response to Histoplasma capsulatum. J Infect Dis 200: 142– 151. 19469707 PMC2715335
  4. [7]Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, et al (2009) Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 182: 4938– 4946. 19342673 PMC3434356
  5. [8]Wüthrich M, Deepe GS Jr, Klein B (2012) Adaptive immunity to fungi. Annu Rev Immunol 30: 115– 148. 22224780 PMC3584681
  6. [9]Gladiator A, Wangler N, Trautwein-Weidner K, Leibundgut-Landmann S (2013) Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 190: 521– 525. 23255360
  7. [10]Igyarto BZ, Haley K, Ortner D, Bobr A, Gerami-Nejad M, et al (2011) Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35: 260– 272. 21782478 PMC3163010
  8. [11]Cua DJ, Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10: 479– 489. 20559326
  9. [12]Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, et al (2013) Innate lymphoid cells–a proposal for uniform nomenclature. Nat Rev Immunol 13: 145– 149. 23348417
  10. [13]Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, et al (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464: 1371– 1375. 20393462 PMC3796764
  11. [14]Geremia A, Arancibia-Carcamo CV, Fleming MP, Rust N, Singh B, et al (2011) IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 208: 1127– 1133. 21576383 PMC3173242
  12. [15]Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Berard M, et al (2011) RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 12: 320– 326. 21336274
  13. [16]Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, et al (2011) Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12: 255– 263. 21278737 PMC3040235
  14. [17]Hasegawa E, Sonoda KH, Shichita T, Morita R, Sekiya T, et al (2013) IL-23-independent induction of IL-17 from gammadeltaT cells and innate lymphoid cells promotes experimental intraocular neovascularization. J Immunol 190: 1778– 1787. 23319736
  15. [18]Coccia M, Harrison OJ, Schiering C, Asquith MJ, Becher B, et al (2012) IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells. J Exp Med 209: 1595– 1609. 22891275 PMC3428945
  16. [19]Lalor SJ, Dungan LS, Sutton CE, Basdeo SA, Fletcher JM, et al (2011) Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J Immunol 186: 5738– 5748. 21471445
  17. [20]Crellin NK, Trifari S, Kaplan CD, Satoh-Takayama N, Di Santo JP, et al (2010) Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 33: 752– 764. 21055975
  18. [21]Glatzer T, Killig M, Meisig J, Ommert I, Luetke-Eversloh M, et al (2013) RORgammat innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 38: 1223– 1235. 23791642
  19. [22]Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321– 330. 19682928
  20. [23]Spits H, Cupedo T (2012) Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 30: 647– 675. 22224763
  21. [25]Xu H, Wang X, Liu DX, Moroney-Rasmussen T, Lackner AA, et al (2012) IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol 5: 658– 669. 22669579 PMC3702374
  22. [26]Li H, Reeves RK (2012) Functional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection. Front Immunol 3: 417. 23316201 PMC3539714
  23. [27]Hepworth MR, Monticelli LA, Fung TC, Ziegler CG, Grunberg S, et al (2013) Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498: 113– 117. 23698371 PMC3699860
  24. [28]Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, et al (2012) Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336: 1321– 1325. 22674331 PMC3659421
  25. [30]Do JS, Visperas A, Dong C, Baldwin WM 3rd, Min B (2011) Cutting edge: generation of colitogenic Th17 CD4 T cells is enhanced by IL-17+ gammadelta T cells. J Immunol 186: 4546– 4550. 21402889 PMC3200541
  26. [31]Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, et al (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331– 341. 19682929
  27. [32]Quintin J, Saeed S, Martens JH, Giamarellos-Bourboulis EJ, Ifrim DC, et al (2012) Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12: 223– 232. 22901542 PMC3864037

Authors
Gladiator, A., & LeibundGut-Landmann, S.
Affiliations
ETH Zurich (CH)
Venue
PLoS Pathogens
Published
2013-12-12
Volume
9
Issue
12
Pages
e1003763
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W1968661266
Cited by
35
References
32
Citations by year
2026: 4 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 5 · 2014: 4
FWCI
2.21
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
Funders
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (123342)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
innate lymphoid cells, IL-17, antifungal immunity, fungal infection, IL-17A, IL-17F, Th17 cells
MeSH terms
Animals, Candida albicans, Fungi, Humans, Immunity, Innate, Lymphocytes, Mice, Transgenic, Mycoses, Interleukin-17, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review